Edition:
United Kingdom

Evoke Pharma Inc (EVOK.OQ)

EVOK.OQ on NASDAQ Stock Exchange Capital Market

3.05USD
21 May 2018
Change (% chg)

-- (--)
Prev Close
$3.05
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
14,108
52-wk High
$4.09
52-wk Low
$1.86

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Dec '17 0.00 -0.020
Sep '17 0.00 -0.342
Jun '17 0.00 -0.106
Mar '17 0.00 -0.373
FY 2016 Dec '16 0.00 -0.124
Sep '16 0.00 -0.285
Jun '16 0.00 -0.412
Mar '16 0.00 -0.450
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Jun-18 4 0.00 0.00 0.00 0.00
Quarter Ending Sep-18 3 0.00 0.00 0.00 0.00
Year Ending Dec-18 3 0.00 0.00 0.00 18.95
Year Ending Dec-19 4 11.74 18.82 0.00 64.37
Earnings (per share)
Quarter Ending Jun-18 3 -0.18 -0.14 -0.24 -0.20
Quarter Ending Sep-18 3 -0.14 -0.06 -0.18 -0.18
Year Ending Dec-18 3 -0.58 -0.40 -0.71 -0.13
Year Ending Dec-19 4 -0.66 -0.34 -0.97 0.51
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 28.56 32.59
P/E High - Last 5 Yrs. -- 41.38 47.07
P/E Low - Last 5 Yrs. -- 23.34 24.59
Beta 1.49 0.80 0.79
Price to Sales (TTM) -- 4.18 9.01
Price to Book (MRQ) 21.71 3.50 4.24
Price to Tangible Book (MRQ) 21.82 4.37 5.79
Price to Cash Flow (TTM) -- 19.51 21.78
% Owned Institutions 26.77 1.29 2.43

Dividends

  Company industry sector
Dividend Yield -- 1.79 1.66
Dividend Yield - 5 Year Avg -- 0.79 0.80
Dividend 5 Year Growth Rate -- 2.73 4.15
Payout Ratio(TTM) -- 16.91 17.73

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 3.99 5.10
Sales (TTM) vs TTM 1 Yr. Ago -- 10.28 12.65
Sales - 5 Yr. Growth Rate -- 7.42 8.10
EPS (MRQ) vs Qtr. 1 Yr. Ago 83.80 37.70 33.25
EPS (TTM) vs TTM 1 Yr. Ago 33.80 -- --
EPS - 5 Yr. Growth Rate -- 7.07 8.54
Capital Spending - 5 Yr. Growth Rate -- 8.26 8.77

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.52 2.50
Current Ratio (MRQ) 3.82 3.58 3.56
LT Debt to Equity (MRQ) 0.00 10.41 12.86
Total Debt to Equity (MRQ) 0.00 12.80 15.83
Interest Coverage (TTM) -39.27 40.27 35.15

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 55.48 54.64
Gross Margin - 5 Yr. Avg. -- 52.71 52.74
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- 18.50 15.84
Operating Margin (TTM) -- 12.71 -2.34
Operating Margin - 5 Yr. Avg. -- 14.23 11.09
Pre-Tax Margin (TTM) -- 13.00 -0.23
Pre-Tax Margin - 5 Yr. Avg. -- 14.51 11.29
Net Profit Margin (TTM) -- 9.41 -3.64
Net Profit Margin - 5 Yr. Avg. -- 10.79 7.58
Effective Tax Rate (TTM) -- 22.43 31.25
Effective Tax Rate - 5 Yr. Avg. -- 23.90 24.61

Efficiency

  Company industry sector
Revenue/Employee (TTM) 0 831,280,368 721,262,098
Net Income/Employee (TTM) -1,747,073 96,677,550 83,813,821
Receivable Turnover (TTM) -- 5.53 5.67
Inventory Turnover (TTM) -- 2.50 3.55
Asset Turnover (TTM) 0.00 0.87 0.85

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -141.90 10.44 9.98
Return on Assets - 5 Yr. Avg. -81.15 11.65 11.07
Return on Investment (TTM) -177.89 13.05 12.60
Return on Investment - 5 Yr. Avg. -94.13 15.07 14.34
Return on Equity (TTM) -410.84 14.79 14.49
Return on Equity - 5 Yr. Avg. -177.24 16.32 15.71
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % 28.68 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Evoke Pharma Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 32.83%
# of Holders: 27
Total Shares Held: 5,507,604
3 Mo. Net Change: 825,331
# New Positions: 0
# Closed Positions: 10
# Increased Positions: 4
# Reduced Positions: 13
# Net Buyers: -9
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.